Foundation Medicine’s new MET (c-Met) IHC offering helps healthcare providers identify patients eligible for a first-in-class MET-directed antibody drug conjugate (ADC) for NSCLC patients with c ...

New platform gives developers direct access to GPUs, AI models, computing tools worldwide ADX-listed IHC delivered a net profit of Dh32 billion plus for 2022. And it keeps steaming ahead with an ...

Abu Dhabi-listed International Holding Company (IHC) has launched an artificial intelligence-driven global reinsurance platform based in ADGM, in partnership with US asset manager BlackRock and ...

A neutralizing antibody therapy targeting the conserved stalk region of the H5N1 hemagglutinin protein reduced disease severity and prevented death in monkeys exposed to avian flu.

Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease. Experts from the University of ...

The report by the IHC registrar office was submitted to a division bench in response to an application, seeking the early hearing of an appeal against the conviction of the PTI founder and his ...

ISLAMABAD: The Islamabad High Court (IHC) has dismissed a writ petition filed against the Chairman of the Implementation Tribunal for Newspaper Employees (ITNE) by Ghulam Murtaza Mughal ...

BlackRock is backing a $1 billion, artificial intelligence-backed reinsurance platform launched by IHC and headquartered in Abu Dhabi. The new platform, which is yet to be named, will serve global ...

New phase 2b/3 trial results with MSD's experimental respiratory syncytial virus (RSV) antibody clesrovimab have fired a shot across the bows of AstraZeneca and Sanofi, currently predicting ...

The FDA has started a review of MSD's respiratory syncytial virus (RSV) antibody clesrovimab, with a verdict due in the middle of next year. If approved by the 10th June action date, clesrovimab ...